BCAT1 synthesizes BCAA from substrates BCKA and glutamate through reversible amination, increasing the pool of BCAA and promoting the proliferation of CML cells. This evidence concerns the gene BCAT1 and chronic myelogenous leukemia, BCR-ABL1 positive.